Devyser partners with Illumina
Devyser has entered into a strategic agreement with Illumina in which Devyser will offer selected Illumina sequencing instruments with Devyser’s reagent solutions.
Webinars and Sponsored Roundtables — Register Now
Tuesday, April 28, 2026, 12:00 PM–1:00 PM ET
Discover how next-day comprehensive genomic profiling (CGP) is possible with the Oncomine Comprehensive Assay Plus on the Genexus System—delivering both speed and accuracy.
Webinar presenters Jane Bayani, MHSc, PhD, Assistant Professor and Co-Director, Diagnostic Development, Ontario Institute for Cancer Research, Canada, and Nicola Normanno, MD, Scientific Director, IRCCS Romagnolo Institute for the Study of Tumors, Italy, and Morten Grauslund, PhD, Molecular Biologist, Department of Pathology, Rigshospitalet/Copenhagen University Hospital, Copenhagen, Denmark.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Thermo Fisher Scientific. For Research Use Only. Not for use in diagnostic applications.
Thursday, April 30, 2026, 11:00 AM–12:00 PM ET
Hear an expert discuss how Memorial Sloan Kettering Cancer Center (MSKCC) is utilizing
the oncoReveal® Nexus 21-gene panel to redefine turnaround time and actionable insights
in cancer care. Dr. Ewalt shares a perceptive look at the clinical need for rapid, front-line NGS sequencing, and how a unique, purpose built targeted NGS panel (Pillar Biosciences’ oncoReveal Nexus 21 gene Panel) was developed, validated and implemented clinically by Memorial Sloan Kettering Cancer Center (MSK-REACT) to complement their current comprehensive genomic profiling (CGP) approach.
Webinar presenter Mark Ewalt, MD, Associate Medical Director for Laboratory Operations for Diagnostic Molecular Pathology in the Molecular Diagnostics Service, Department of Pathology and Laboratory Medicine, MSKCC.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Pillar Biosciences.
Thursday, May 28, 2026, 1:00–2:00 PM ET
This session is designed to improve understanding and application of recent updates to synoptic pathology reporting protocols such as the latest Reporting Template for Reporting Results of Biomarker Testing of Specimens from Patients with Carcinoma of the Breast. These changes reflect evolving clinical guidelines that directly influence diagnostic accuracy and treatment selection in breast cancer care.
Webinar presenters Thaer Khoury, MD, FCAP, Chair, Pathology and Laboratory Medicine, Roswell Park Comprehensive Cancer Cente, and Colin Murphy, CEO of mTuitive.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Subspecialties
Interactive Product Guides
Marketplace
Invivoscribe launches RUO leukemia assay, software
April 2026—Invivoscribe has added the LeukoStrat KMT2A + MRD assay and software to its oncology portfolio.
Siemens launches RUO blood-based tau assays
April 2026—Siemens Healthineers has launched the Atellica IM Phosphorylated tau 217 and Atellica IM Brain Derived Tau assays for research use.
Illumina launches TruPath Genome
April 2026—Illumina has launched TruPath Genome, which provides high-quality, comprehensive whole genome insights for genetic disease. It features a hands-on time of about 10 minutes and generates 16 whole genomes per day.
HelioLiver test available to Quest providers
April 2026—Helio Genomics’ blood-based HelioLiver test is now available to physicians and patients through Quest Diagnostics.
Illumina launches software for multiomic analysis
March 2026—Illumina has released Illumina Connected Multiomics, a cloud-based research software platform to analyze and visualize multiomic and multimodal biological data at scale.
FDA clears Cepheid Xpert GI multiplex PCR test
March 2026—Cepheid received FDA clearance for its Xpert GI panel, a multiplex PCR test designed to detect gastrointestinal pathogens from a single patient sample.
Agilent launches S540MD slide scanner system
March 2026—Agilent Technologies launched the Agilent S540MD slide scanner system, a whole slide imaging digital scanner available for sale in select European markets.
Zepto launches plasma-based FungiFlex Mold panel
March 2026—Zepto Life Technology has launched the FungiFlex Mold panel.
ASI acquires ELISA product line
March 2026—Arlington Scientific has completed its acquisition of Awareness Technology’s EIA/ELISA product line.